Spotlight

Project Updates

  • The OPTIONS Consortium objective is to develop a streamlined, adaptable product delivery platform for current and future ARV-based HIV prevention options, with a particular focus on women.

    • OPTIONS develops communication strategy for Lesotho’s oral PrEP roll out.
    • OPTIONS hosts dapivirine ring modeling stakeholder consultation.
    • Operations research underway.
    • PrEPWatch re-organized and new resources added.
    • Mapping of PrEP trials and implementation projects updated.

    Read more >


  • POWER develops cost-effective and scalable models for implementation of ARV-based HIV prevention products for women.

    • Cohorts in Cape Town, Johannesburg, and Kisumu enroll more than 200 young women.
    • My PrEP decision support tool ready to launch; additional demand creation tools in development.
    • POWER team meeting convened.

    Read more >


  • EMOTION increases uptake and correct and consistent use of ARV-based HIV prevention products by women at high risk of HIV infection using an end-user centered strategy.

    • Project VOGUE continues.

     

    Read more >


  • CHARISMA supports efforts to: increase women’s agency to safely use ARV-based HIV prevention, to engage male partners in HIV prevention, and to overcome harmful gender norms and reduce intimate partner violence (IPV).

    • Clinic-based intervention continues.
    • Community-based intervention completed in September.
    • CHARISMA pilot evaluation underway and effectiveness study planned.

     

    Read more >


  • GEMS informs policies and defines programmatic considerations related to use of ARV-based HIV prevention products and risk of resistance.

    • Genital swabs testing begins and assay development is underway.
    • Drug resistance testing in Kenya progresses.
    • Drug resistance testing in South Africa planned.
    • Collaboration in Zimbabwe begins.
    • GEMS to offer technical assistance on drug resistance testing.
    • Oral PrEP modeling progresses.

    Read more >